Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Marvell in conjunction with the acquisition of Xelerated
Mandate

Vinge advises Marvell in conjunction with the acquisition of Xelerated

January 11, 2012

Vinge has advised Marvell Semiconductors Inc., the world leader within semiconductor solutions and quoted on NASDAQ in conjunction with the acquisition of Xelerated, which provides technology solutions for industrial networks. Xelerated’s majority owner is the Sixth AP fund.

Vinge’s team consisted of partner Johan Winnerblad together with, among others, associates Paul Dali and Albert Wållgren. Partner Fredrik Dahl and associate Åsa Gotthardsson provided advice on the employment law aspects of the transaction and partner Mattias Schömer and associate Tora Hansjons provided tax law advice.

Related

Vinge advises Irisity in connection with issue of units

 Vinge advises Irisity AB (publ) in connection with its rights issue of units consisting of shares and warrants. The issue is guaranteed to 80 per cent through subscription commitments and external guarantors.
October 03, 2024

Vinge has advised the municipality of Varberg in legal proceedings regarding a detailed development plan for a new residential area

 The detailed development plan for approximately 50 new homes in Trönningenäs, north of the city of Varberg, was adopted by the municipality on 23 February 2023. It was subsequently appealed in several stages. By decision of the Land and Environment Court of Appeal, the plan become legally binding on 2 October 2024.
October 03, 2024

Vinge has advised Egetis Therapeutics in connection with directed share issuances

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with directed share issuances whereby Egetis Therapeutics receives gross proceeds of SEK 300 million.
October 03, 2024